SCHEMBL2000878

SCHEMBL2000878

C=CCOC(=O)c1ccsc1N

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.58
HSD17B10 Q99714 3/20 0.58
TSHR P16473 1/20 0.58
CYP3A4 P08684 2/20 0.57
MEN1 O00255 6/20 0.49
KMT2A Q03164 6/20 0.49
MAPT P10636 4/20 0.49
MAPK1 P28482 2/20 0.49
LMNA P02545 2/20 0.42
USP2 O75604 1/20 0.42
GLA P06280 1/20 0.42
RAB9A P51151 2/20 0.41
NPC1 O15118 1/20 0.41
SNCA P37840 1/20 0.39
KDM4E B2RXH2 2/20 0.39
TP53 P04637 1/20 0.39
HPGD P15428 1/20 0.39
TDP1 Q9NUW8 1/20 0.38
RHOA P61586 1/20 0.38
GAA P10253 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18984964 0.82 CYP3A4 (0.59) ALDH1A1HSD17B10TSHRCYP3A4MEN1
SCHEMBL11043471 0.79 CYP3A4 (0.56) ALDH1A1HSD17B10TSHRCYP3A4MEN1
SCHEMBL225275 0.78 ALDH1A1 (0.54) ALDH1A1HSD17B10TSHRCYP3A4MEN1
SCHEMBL4786272 0.77 ALDH1A1 (0.54) ALDH1A1HSD17B10TSHRCYP3A4MEN1
SCHEMBL17147852 0.77 ALDH1A1 (0.58) ALDH1A1HSD17B10TSHRCYP3A4MEN1
SCHEMBL1992502 0.76 CYP3A4 (0.51) ALDH1A1HSD17B10TSHRCYP3A4MEN1
SCHEMBL8041829 0.75 CYP3A4 (0.73) ALDH1A1HSD17B10TSHRCYP3A4MEN1
SCHEMBL5278956 0.74 ALDH1A1 (0.60) ALDH1A1HSD17B10TSHRCYP3A4MEN1
Bicarbonate SCHEMBL20838538 0.74 CYP3A4 (0.92) ALDH1A1HSD17B10TSHRCYP3A4MEN1
SCHEMBL759012 0.73 ALDH1A1 (1.00) ALDH1A1HSD17B10TSHRCYP3A4MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2346861-B1 THIOPHENE CONTAINING ANALOGUES OF FLUCONAZOLE AS ANTIFUNGAL AGENTS AND PROCESS THEREOF COUNCIL SCIENT IND RES (IN) 2013-01-23 EP disclosed
US-8236840-B2 Thiopene containing analogues of fluconazole as antifungal agents and process for their preparation COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2012-08-07 US disclosed
EP-2346861-A2 THIOPHENE CONTAINING ANALOGUES OF FLUCONAZOLE AS ANTIFUNGAL AGENTS AND PROCESS THEREOF Council of Scientific and Industrial Research (IN) 2011-07-27 EP disclosed
US-20110144171-A1 THIOPENE CONTAINING ANALOGUES OF FLUCONAZOLE AS ANTIFUNGAL AGENTS AND PROCESS FOR THEIR PREPARATION COUNCIL OF SCIENCE & INDUSTRIAL RESEARCH (IN) 2011-06-16 US disclosed
WO-2010046912-A2 THIOPHENE CONTAINING ANALOGUES OF FLUCONAZOLE AS ANTIFUNGAL AGENTS AND PROCESS THEREOF COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2010-04-29 WO disclosed
EP-0234557-B1 3-(1H-Tetrazol-5-yl)thieno[2,3-d]pyrimidin-4(3H)-ones MERRELL DOW PHARMACEUTICALS INC. (US) 1990-11-28 EP disclosed
US-4761474-A 3-(1H-tetrazol-5-yl)thieno[2,3-d]pyrimidin-4(3H)-ones MERRELL DOW PHARMACEUTICALS INC. (US) 1988-08-02 US disclosed
EP-0234557-A1 3-(1H-Tetrazol-5-yl)thieno[2,3-d]pyrimidin-4(3H)-ones MERRELL DOW PHARMACEUTICALS INC. (US) 1987-09-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110144171-A1 THIOPENE CONTAINING ANALOGUES OF FLUCONAZOLE AS ANTIFUNGAL AGENTS AND PROCESS FOR THEIR PREPARATION CYP51A1, ERG28, TPMT ALDH1A1 2097/4885HSD17B10 1689/4885TSHR 3134/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.